Company: AVCRF
Filing Date: 2025-06-16
Form Type: 20-F
Source: 0001641172-25-015266
Chunk: 6

Company: Avricore Health Inc.
Filing Date: 2025-06-16
Form: 20-F
Item: Item 3
Chunk 6
---
,000,000 for the preceding three years; (2) except for purposes of Section 7(b) of the Exchange Act and Rule 419, any security that
has a price of $5.00 or more; and (3) a security that is authorized or approved for authorization upon notice of issuance for quotation
on the NASDAQ Stock Market, Inc.’s Automated Quotation System. It is likely that the Company’s common shares, assuming a
market were to develop in the US, will be subject to the regulations on penny stocks. Consequently, the market liquidity for the common
shares may be adversely affected by such regulations limiting the ability of broker/dealers to sell the Company’s common shares
and the ability of shareholders to sell their securities in the secondary market in the US Moreover, the Company shares may only be sold
or transferred by the Company shareholders in those jurisdictions in the US in which an exemption for such “secondary trading”
exists or in which the shares may have been registered.

There
is no guarantee that there is a market for the Company’s common shares in the United States.

Although
the Company’s common shares were added to the OTC Bulletin Board System on April 20, 2009 under the symbol “ APCSF”,
and the Company’s common shares are currently trading on the OTCQB under the symbol “ AVCRF”, trading of the Company’s
shares is very limited. The Company cannot guarantee that there will be a market for the Company’s common shares in the United
States or that there will any significant amount trading in the Company’s shares for the foreseeable future. The Company cannot
guarantee that it will continue to maintain a listing in the United States or that it will not be found in default of existing regulations
or new regulations and be suspended from trading or delisted.

Risks
Pertaining to the Industry

There
is a risk of competition from alternative POCT platforms

Although
competition is currently limited competitors may emerge offering alternative platforms. The Company will be competing with companies
that are potentially already entrenched in some markets or may be better funded than the Company.

There
is a risk that the Company’s intellectual property infringes upon the rights of other companies, which could lead to reduced revenues,
reduced margins due to sanctions against the Company, outright withdrawal or prohibition of products or trademarks from the market and
significant costs for legal defense against infringement claims, re-branding of products and revised marketing materials.

The
Company is unaware of any infringement claims being